Abstract:Nanoparticle-anchored platelet systems hold great potential to act as drug carriers in post-surgical cancer treatment due to the intrinsic targeting ability to bleeding sites. However, rational design is still needed to further improve its cargo release profiles to meet cytosolic delivery of therapeutic proteins with intracellular targets. Herein, we develop a tumor microenvironment (TME)-responsive backpack-conjugated platelet system to enhance intracellular protein delivery to inhibit tumor recurrence after surgery. Specifically, protein nanogels encapsulating GALA and Granzyme B (GrB) are conjugated on the platelet surface via an acid-sensitive benzoic-imine linker through a biorthogonal reaction (GALA-GNGs-P). Taking advantage of wound-tropism of platelets, GALA-GNGs-P could actively accumulate at the surgical trauma and release nanogels in response to acidic TME for promoting deep penetration. Following cellular uptake, the pore-forming peptide GALA helps nanogels escape from lysosome. Subsequently, high glutathione (GSH) concentration in tumor cytoplasm facilitates GrB release from NGs, leading to intense cell apoptosis. GALA-GNGs-P shows remarkable tumor-targeting capability, high cellular uptake, and outstanding lysosomal escaping ability, leading to significant inhibition of tumor recurrence in mice models with incomplete tumor resection. Our findings indicate that platelets bioengineered with TME-responsive protein nanogels provide an option to intracellularly deliver therapeutic proteins for post-surgical treatment of cancer. Statement of significance Platelet-based drug delivery systems (DDSs) have gained considerable achievements in post-surgical cancer treatment. However, there was no research exploring their potential in realizing the controllable release of cargoes in the acidic tumor microenvironment (TME). Herein, we construct a TME-responsive bioengineered platelet delivery platform (GALA-GNGs-P) for achieving controllable and effective protein intracellular delivery to overcome post-surgical tumor recurrence. Our surface-anchored nanogel-platelet system has the following advantages: (i) improving the loading efficiency of therapeutic proteins, (ii) affecting no physiological function of platelets, (iii) realizing on-demand cargo release in the acidic TME, and (iv) helping proteins escape from endosomal entrapment. Our findings further explored the prospect of cellular backpack system and realized the controllable release of cargoes in the acidic TME.

Platelet-hitchhiking Biomimetic Nanoplatforms Pry Precisely Tumor Seed and Growing Soil for Inhibiting Tumor Recurrence and Metastasis

Targeted Inhibition of Tumor Inflammation and Tumor-Platelet Crosstalk by Nanoparticle-Mediated Drug Delivery Mitigates Cancer Metastasis.

Nanoplateletsomes Restrain Metastatic Tumor Formation Through Decoy and Active Targeting in a Preclinical Mouse Model.

Platelet-Mimicking Biotaxis Targeting Vasculature-Disrupted Tumors for Cascade Amplification of Hypoxia-Sensitive Therapy

Platelet Activation-Induced in Situ Trapping Metastatic Tumor Cells Strategy for Post-Surgery Tumor Recurrence Immunochemotherapy.

Platelet Pharmacytes for the Hierarchical Amplification of Antitumor Immunity in Response to Self-Generated Immune Signals.

Platelet-promoting Drug Delivery Efficiency for Inhibition of Tumor Growth, Metastasis, and Recurrence

Antitumor Platelet‐Mimicking Magnetic Nanoparticles

Fucoidan-functionalized Activated Platelet-Hitchhiking Micelles Simultaneously Track Tumor Cells and Remodel the Immunosuppressive Microenvironment for Efficient Metastatic Cancer Treatment.

Correction to Blockade of Platelets Using Tumor-Specific NO-Releasing Nanoparticles Prevents Tumor Metastasis and Reverses Tumor Immunosuppression

Double-sided Effect of Tumor Microenvironment on Platelets Targeting Nanoparticles.

Biodegradable Electrospun Nanofibrous Platform Integrating Antiplatelet Therapy-Chemotherapy for Preventing Postoperative Tumor Recurrence and Metastasis.

Activated Platelets‐Targeting Micelles with Controlled Drug Release for Effective Treatment of Primary and Metastatic Triple Negative Breast Cancer

Platelet-Based Nanoparticles with Stimuli-Responsive for Anti-Tumor Therapy

Platelet membrane-based and tumor-associated platelettargeted drug delivery systems for cancer therapy

Surface-anchored tumor microenvironment-responsive protein nanogel-platelet system for cytosolic delivery of therapeutic protein in the post-surgical cancer treatment

A platelet-mimicking theranostic platform for cancer interstitial brachytherapy

Bioinspired Platelet-like Nanovector for Enhancing Cancer Therapy via P-Selectin Targeting

T Cell-Mimicking Platelet-Drug Conjugates

Biomimetic nano-NOS mediated local NO release for inhibiting cancer-associated platelet activation and disrupting tumor vascular barriers

Targeting self-assembly peptide for inhibiting breast tumor progression and metastasis.